NCT05113472View on ClinicalTrials.gov

Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers

CompletedOBSERVATIONAL
Enrollment

1,291

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Adverse Drug Event
Interventions
BIOLOGICAL

Pfizer-BioNTech COVID-19 vaccine

Patients who were administered any dose of the Pfizer-BioNTech COVID-19 vaccine.

Trial Locations (1)

092301

Universidad Espiritu Santo, Samborondón

All Listed Sponsors
lead

Respiralab

OTHER

NCT05113472 - Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers | Biotech Hunter | Biotech Hunter